Not a good buy right now for an impatient buyer: the setup is extended/overbought (RSI-6 at 84), increasing near-term pullback risk.
Trend is bullish (SMA_5 > SMA_20 > SMA_200 and MACD expanding), but without Intellectia buy signals today, the risk/reward at 21.88 is less attractive than buying on a dip.
Options positioning is mildly-to-strongly bullish (calls favored), but actual volume is very small, so the signal quality is limited.
Latest quarter (2026/Q2) showed weakening earnings (-29% net income, -28.6% EPS YoY), which reduces fundamental momentum support for chasing a breakout.
No recent news catalysts and no notable hedge fund/insider trend—nothing forcing urgency to buy immediately.
Momentum: MACD histogram +0.145 and expanding (supports continuation), but RSI-6 = 84.28 (overbought / crowded short-term).
Levels: Price 21.88 is above R1 (21.6) and approaching R2 (22.324); pivot support at 20.427. A pullback toward ~20.4–21.6 would be a cleaner entry than buying at 21.88.
Pattern-based odds (provided): ~60% chance of only +0.16% next day, -1.92% next week, +4.71% next month → suggests near-term chop/softness despite a better 1-month outlook.
Sentiment: Put/Call OI ratio 0.66 and put/call volume ratio 0.08 indicate bullish positioning (more calls than puts).
Liquidity caveat: Total options volume is tiny (14 contracts; puts volume = 1), so sentiment read-through is weaker than it looks.
Volatility/pricing: 30D IV 52.74 vs historical vol 28.98 → options are relatively expensive; IV is also below 5D/10D IV averages (66.45/63.31), suggesting IV has been coming down recently.
Net takeaway: Slightly bullish options skew, but not strong enough (given low volume) to justify chasing an overbought spot entry.
Cons: weakening YoY earnings and revenue; no near-term catalysts indicated.
Wall Street analysts forecast MLKN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLKN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast MLKN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLKN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
